Nuclear Medicine Department

The development of Quarkmed's nuclear medicine business has benefited from the rapid development of radiopharmaceuticals in China. After more than five years of development, Quarkmed has been committed to deeply engaging in nuclear medicine clinical services, improving and equipping its nuclear medicine team, and gradually accumulating project experience. The Nuclear Medicine Division of Quarkmed has rich experience ranging from registration to clinical operation. It is capable of providing a series of services such as registration services, clinical operation, and commercialization empowerment for radiopharmaceuticals, radiotherapy and imaging, and isotope tracer products. The nuclear medicine business segment of Quarkmed has gradually formed relatively comprehensive clinical research service capabilities.

Clinical project experience (including but not limited to):

• Breast cancer (Diagnostics)

• Alzheimer's disease (Diagnostics)

• Pulmonary carcinoma (Diagnostics)

• Bone metastases (Diagnostics)

• Myocardial perfusion (Diagnostics)

• Cerebral colloid carcinoma

• Prostatic cancer

• Hepatic cancer

• Endocrine neoplasm